Candillada, Baby Boy .
HRN: 28-79-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/10/2026
04/16/2026
IVT
45mg
Q24H
Neonatal Asphyxia; Neonatal Pneumonia
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: